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Background: Acute kidney injury (AKI) is a serious complication after cardiac surgery that 
is associated with increased mortality and morbidity. Heme oxygenase-1 (HO-1) is an enzyme 
synthesized in renal tubular cells as one of the most intense responses to oxidant stress linked 
with protective, anti-inflammatory properties. Yet, it is unknown if serum HO-1 induction fol-
lowing cardiac surgical procedure involving cardiopulmonary bypass (CPB) is associated with 
incidence and severity of AKI.
Patients and methods: In the present study, we used data from a prospective cohort study of 
150 adult cardiac surgical patients. HO-1 measurements were performed before, immediately 
after and 24 hours post-CPB. In univariate and multivariate analyses, the association between 
HO-1 and AKI was investigated.
Results: AKI with an incidence of 23.3% (35 patients) was not associated with an early eleva-
tion of HO-1 after CPB in all patients (P=0.88), whereas patients suffering from AKI developed 
a second burst of HO-1 24 hours after CBP. In patients without AKI, the HO-1 concentrations 
dropped to baseline values (P=0.031). Furthermore, early HO-1 induction was associated with 
CPB time (P=0.046), while the ones 24 hours later lost this association (P=0.219).
Conclusion: The association of the second HO-1 burst 24 hours after CBP might help to dis-
tinguish between the causality of AKI in patients undergoing CBP, thus helping to adapt patient 
stratification and management.
Keywords: acute kidney injury, cardiac surgery, heme oxygenase-1, cardiopulmonary bypass
Introduction
Surgery-associated acute kidney injury (AKI) is a common and serious complication 
after cardiac surgery, which increases the risk of mortality, morbidity as well as length 
of the hospital stay.1–6 The incidence of AKI associated with cardiac surgery may reach 
50%,3,7–10 depending on the definition. The diagnosis of AKI is suggested by the Kidney 
Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group as 
an increase in serum creatinine (SCr) and/or a decrease in urine production.11 Even 
slight elevation of 0.3 mg/dL (AKI stage I) in SCr is considered as an independent 
predictor of in-hospital, 30-day as well as long-term mortality.12,13 Direct therapy for 
AKI is limited by the supportive strategy that includes fluid management, adequate 
drug dosing and dialysis for severe AKI stages.
Early prediction of AKI might allow an interventional therapeutic regime at the 
intensive care unit (ICU) before the damage of glomerular or renal tubular cells tends 
to become high grade or even irreversible. Furthermore, early distinction of the stages 
and causes of AKI might help in decision making in the ICU regarding catecholamine 
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therapy, dialysis or fluid/drug management in early postop-
erative care.
The inducible isoform enzyme heme oxygenase-1 (HO-1) 
catalyzes the oxidative degradation of heme, producing CO, 
Fe2+ and biliverdin, which is converted to bilirubin by cytosolic 
biliverdin reductase. HO-1 is upregulated in proximal tubu-
lar cells as a response to oxidative stress and has protective 
anti-inflammatory and anti-oxidant effects.14 HO-1 was first 
recognized as a rapid and protective response in the context 
of rhabdomyolysis and heme pigment-induced AKI in animal 
models.14 The beneficial effects of HO-1 on oxidative stress 
and prevention of AKI have been reported in multiple animal 
models.15–17 In one small cohort in cardiac surgery, the asso-
ciation with AKI has been suggested in a clinical setting.18
In this prospective cohort study, we aimed to evaluate the 
course of HO-1 serum concentration after cardiac surgery 
and the association with AKI.
Patients and methods
Patient population
We enrolled in this prospective cohort study 165 patients 
between April and December 2014. Adult patients undergoing 
elective cardiac surgical procedure involving cardiopulmo-
nary bypass (CPB) (coronary artery bypass graft [CABG], 
valve surgery [reconstruction, replacement] or combined 
CABG and valve surgery, and surgery of the thoracic aorta) 
were included. Patients signed informed consent form. 
Patients with chronic kidney disease (CKD) stage 3 or higher, 
ie, eGFR <30 mL/min, with signs of active infection (clini-
cal assessment), women during pregnancy and lactation, as 
well as patients on COMT inhibitors, MAO inhibitors or on 
immunosuppression were excluded. Patient enrollment was 
at least 24 hours prior to surgery. Demography, medical his-
tory, medication, details of physical examination, anesthesia 
details, surgical data and the postoperative data including the 
hospital discharge were collected by the study personnel and 
were completed by the Comprehensive Heart Failure Center 
DataWarehouse.19 The study protocol was approved by the 
ethics committee at the Medical Faculty of the University of 
Würzburg (Vote 302/13) and the data protection officer at 
the University Hospital Würzburg.
Biomarker measurements
We collected blood samples at a predefined time schedule 
(preoperatively; at admission in ICU; 6, 24, and 48 hours after 
surgery; and at discharge from hospital). These time points 
were defined by local clinical routine; samples were collected 
by treating staff, while further processing was performed by 
study personnel. All samples were processed and stored at 
−80°C. For biomarker analyses, serum samples were thawed 
at +4°C and HO-1 (Enzo LifeSciences, Ann Arbor, MI, USA).
Neutrophil gelatinase-associated lipocalin (NGAL; BioPorto 
Diagnostics A/S, 2900 Hellerup, Denmark) concentrations
were measured by ELISA following the manufacturer’s
guides. HO-1 was measured at anesthesia induction (base-
line), at admission in the ICU and on postoperative day 1 (24 
hours postsurgery), while NGAL was measured at baseline
and at admission in the ICU.
Definition of end points and outcomes
The primary end point of the study was the incidence of AKI 
within 48 hours after surgery. The severity of postoperative 
AKI is defined as any of the following: 1. SCr increase by 
≥0.3 mg/dL within 48 hours; or 2. increase in SCr to ≥1.5
times baseline, which is known or presumed to have occurred
within the prior 7 days; or 3. urine volume <0.5 ml/kg/h for 6 
hours. The stages of AKI within 48 hours were defined as SCr 
increase ≥0.3 mg/dL or of 1.5–1.99 times baseline as (stage 1),
SCr increase of 2.0–2.9× baseline (stage 2) and SCr increase
≥3.0 times baseline or SCr >4 mg/dL or dialyses (stage 3).
Secondary end points were the length of stay in ICU and hos-
pital, time on mechanical ventilation and in-hospital mortality.
EuroScore II is a mortality risk calculator for cardiac 
surgical patients considering age, gender, pulmonary disease, 
extracardiac arteriopathy, neurological status, renal status, 
cardiac status as well as the complexity of the planned pro-
cedure.20 The EuroScore II is therefore a reliable score to rate 
the preoperative status of the patient. CPB time represents the 
duration of the operation in which the myocardium suffers from 
oxidative stress.21 Furthermore, it represents a sound surrogate 
marker for the course of the operation and is an independent 
predictor of mortality and morbidity after cardiac surgery.22
statistical analyses
Statistical tests were performed with IBM SPSS 23 Statistics-
Software. Continuous variables were described as medians 
with interquartile range. Categorical variables were presented 
as numbers and percentages. Normally distributed variables 
were compared regarding AKI yes/no by t-test, parametric 
variables by Mann–Whitney U test. Fisher’s exact or the chi-
squared test was used for categorical values. Correlations 
were evaluated by Pearson’s rank correlation test. Univariate 
and adjusted multivariate logistic regression analyses were 
performed to investigate associations between predictors of 
development of AKI including clinically relevant variables 
and renal biomarkers. Variables were included in the multi-
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variable analysis using a backward stepwise approach with 
criteria of P<0.05 for inclusion and P>0.10 for removal 
from the model. Areas under the curve of receiver operat-
ing characteristic (ROC) were analyzed to assess the cutoff 
value for postoperative HO-1 levels for predicting AKI. 
The optimal HO-1 cutoff level was defined as the value that 
provided the highest sensitivity and specificity for predicting 
AKI. An explorative, two-sided P-value of less than 0.05 was 
considered significant for all results.
Results
Patients’ characteristics
Of the enrolled 165 patients, 15 were excluded due to 
withdrawal of consent and change of surgical procedure to 
off-pump surgery. The patients’ characteristics stratified by 
development of AKI are displayed in Table 1.
Patients experiencing AKI within 48 hours after 
 surgery were older (70 [65–77] vs 65 [59–75] years, 
P=0.015) and more likely to report on stroke or transient 
ischemic attack (TIA) in the medical history (P=0.013). 
EuroScore II tended to be higher without reaching statisti-
cal significance in patients with AKI (1.78 [1.15–3.50] vs 
1.63 [0.89–2.77], P=0.055). Moreover, the time on CPB 
(109 [88–127] vs 110 [66–270], P=0.04) was longer in 
patients with AKI as compared to those without AKI. 
Patients with AKI also spent more time on mechanical 
ventilation (14 [11–23] vs 12 [10–15] hours, P=0.006) 
and in the ICU (55 [22–96] vs 23 [21–44] hours, P=0.001) 
Table 1 Patients’ characteristics according to aKI in 48 hours postoperatively
Characteristics No AKI (n=115) AKI (n=35) P-value
Preoperative
Female, n (%) 33 (28.7) 9 (25.7) 0.83
age (years) 65 (59–75) 70 (65–77) 0.015
height (cm) 178 (172–180) 167 (161–170) 0.18
Weight (kg) 82 (74–90) 81 (75–92) 0.37
Waist circumference (cm) 104 (98–108) 109 (104–116) 0.58
aMI in medical history, n (%) 25 (21.7) 6 (17.1) 0.64
Pacemaker/IcD, n (%) 13 (11.3) 3 (8.6) 0.76
hypertension, n (%) 90 (78.3) 25 (71.4) 0.49
Diabetes mellitus, n (%) 24 (20.9) 4 (11.4) 0.32
Renal impairment, n (%) 7 (6.1) 1 (2.9) 0.68
cOPD, n (%) 5 (4.3) 2 (5.7) 0.66
Peripheral artery disease, n (%) 32 (27.8) 11 (31.4) 0.67
euroscore II 1.63 (0.89–2.77) 1.78 (1.15–3.50) 0.05
stroke/TIa, n (%) 6 (5.2) 7 (20.0) 0.013
Intraoperative
caBg, n (%) 67 (58.3) 19 (54.3) 0.7
Valve surgery, n (%) 61 (53.0) 19 (54.3) 0.999
caBg/valve in combination, n (%) 12 (10.4) 3 (8.5) 0.999
aortic surgery, n (%) 10 (8.7) 5 (14.3) 0.34
cardiac re-operation, n (%) 12 (10.4) 3 (8.6) 0.999
Dhca, n (%) 8 (7.0) 3 (8.6) 0.71
Operation time (minutes) 229 (193–260) 212 (204–345) 0.013
cPB time (minutes) 109 (88–127) 110 (66–270) 0.04
Postoperative
Mechanical ventilation (h) 12 (10–15) 14 (11–23) 0.006
length of stay in IcU (h) 23 (21–44) 55 (22–96) 0.001
Resuscitation, n (%) 3 (2.6) 2 (5.7) 0.33
Mortality, n (%) 0 (0) 5 (14.3) 0.001
ssI, n (%) 2 (1.7) 0 (0) 0.999
aMI postoperative, n (%) 1 (0.9) 1 (2.9) 0.41
hemodynamic instability, n (%) 8 (7.0) 9 (25.7) 0.005
Noradrenalin dose (mg) 2.25 (0.94–5.58) 5.76 (2.37–18.7) <0.001
Rethoracotomy, n (%) 5 (4.3) 3 (8.6) 0.39
Respiratory failure, n (%) 5 (4.3) 4 (11.4) 0.21
Transfusions, n (%) 35 (30.4) 22 (62.9) 0.001
arrhythmia, n (%) 33 (28.7) 15 (42.9) 0.14
Delirium, n (%) 6 (5.2) 2 (5.7) 0.999
Notes: Data is presented as median (IQR25, IQR75). The bold values are statistically significant.
Abbreviations: aKI, acute kidney injury; aMI, acute myocardial infarction; caBg, coronary artery bypass graft; cOPD, chronic obstructive pulmonary disease; cPB, 
cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest; ICD, implantable cardioverter defibrillator; ICU, intensive care unit; SSI, surgical site infection; TIA, 
transient ischemic attack.
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and were also at high risk of in-hospital death (14.3% vs 
0%, P=0.001).
Preoperative SCr levels did not differ between patients 
who developed AKI compared with patients who did not 
(AKI: 1.00 [0.78–1.23] vs no-AKI: 0.90 [0.75–1.02] mg/
dL; P=0.535; Table 2, Figure 1). Neither preoperative serum 
NGAL nor HO-1 levels differed between patients who sub-
sequently developed AKI and those who did not (Table 2, 
Figures 2 and 3). Both markers were higher at ICU arrival 
as compared to baseline (P<0.001 for NGAL and HO-1) 
(Table 2, Figures 2 and 3). NGAL levels were significantly 
higher in patients who developed AKI within 48 hours (960 
[614–1,262] pg/mL vs 600 [461–783] pg/mL, P<0.001), 
while HO-1 levels did not differ (P=0.88) at this time point 
(Table 2, Figures 2 and 3). In patients developing AKI, an 
additional increase of serum HO-1 levels 24 hours after sur-
gery was observed, whereas in patients who subsequently did 
not develop AKI, serum HO-1 levels decreased (AKI: 12.75 
[8.69–34.35] ng/mL vs no AKI: 8.30 [4.13–15.60] ng/mL, 
P=0.031; Table 2 and Figures 2 and 3). In total, 45 patients 
(30%) developed AKI during the first 7 days after surgery and 
three patients required renal replacement therapy (Table 3). 
The severity of AKI is described in Table 3.
The results of univariate and multivariate logistic regres-
sion analyses are presented in Table 4. We analyzed the 
relationship of clinical relevant variables (age, EuroScore 
II, hypertension, diabetes, chronic obstructive pulmonary 
disease, peripheral artery disease, stroke in medical history, 
CPB time, deep hypothermic circulatory arrest, mechanical 
ventilation time, noradrenalin dose, resuscitation, hemody-
namic instability, rethoracotomy and transfusions) and serum 
HO-1 levels with AKI. We found an independent relationship 
of serum HO-1 levels 24 hours after surgery with the devel-
opment of AKI (P=0.043, OR 1.053, 95% CI: 1.002–1.107).
CPB time of all patients was associated with HO-1 levels 
at ICU arrival (P=0.046, correlation coefficient=0.236) but 
not with HO-1 levels at 24 hours after surgery (P=0.219). 
Furthermore, HO-1 levels at 24 hours after surgery in patients 
with AKI were associated with EuroScore II (P=0.048, corre-
lation coefficient=0.181). Using ROC analyses, we provided 
a comparison of AUC between creatinine, NGAL postopera-
tively and HO-1 at 24 hours after surgery (Figure 4). Data are 
summarized in Table 5. By contrast, diagnostic accuracy for 
HO-1 at 24 hours after cardiac surgery was more reliable with 
a sensitivity of 75% and specificity of 85.8% for predicting 
AKI stage 2/3 after 48 hours (AUC 0.802, SE=0.102, 95% 
CI: 0.602–1.000, P=0.004; Figure 5).
Discussion
In the present study, we investigated data from a prospective 
cohort study of 150 adult cardiac surgical patients. Our results 
indicate that HO-1 kinetics differ in patients developing AKI 
within 48 hours from those who do not. All patients – inde-
pendent from subsequent incidence of AKI – showed an HO-1 
increase immediately after the operation. While AKI patients 
showed a second burst 24 hours after surgery, HO-1 levels in 
patients without AKI decreased almost to baseline values. In 
multivariate analyses, HO-1 levels at 24 hours after surgery 
remained associated with AKI within 48 hours. HO-1 showed 
a stronger association with higher stages of AKI (stages 2 
and 3) compared with the AKI stage 1 in the measurement 
24 hours after the surgery. Further investigations showed that 
NGAL concentrations increased early after surgery and were 
associated with the incidence of AKI within 48 hours as well.
AKI, as defined by the most recent guidelines, has a very 
strict definition as a rise in SCr of ≥0.3 mg/dL within 48 
hours.11 Although a slight increase of SCr within 48 hours 
might not get noticed by the treating physicians in absence 
of a significant change of urine production, AKI stage 1 
impacts the prognosis of a patient.6,8,9,23–25 Not only regard-
ing an increased in-hospital mortality – as also confirmed 
in our cohort – but also the long-term prognosis of the 
Table 2 serum creatinine levels preoperatively, 6, 24 and 48 hours postoperatively; plasma Ngal levels preoperatively and at arrival 
in IcU, plasma hO-1 levels preoperatively, at arrival in IcU and 24 hours postoperatively according to aKI 24 hours postoperatively
All patients No AKI AKI P-value
creatinine preoperative (mg/dl) 0.92 (0.76–1.04) 0.90 (0.75–1.02) 1.00 (0.78–1.23) 0.535
creatinine 6 h (mg/dl) 1.01 (0.83–1.04) 0.95 (0.78–1.11) 1.21 (1.09–1.50) 0.001
creatinine 24 h (mg/dl) 0.99 (0.81–1.23) 0.90 (0.75–1.04) 1.37 (1.20–1.78) <0.001
creatinine 48 h (mg/dl) 0.97 (0.83–1.27) 0.89 (0.77–1.07) 1.68 (1.32–2.06) <0.001
Ngal preoperative (pg/ml) 352 (278–466) 336 (271–468) 360 (304–616) 0.80
Ngal IcU (pg/ml) 628 (490–828) 600 (461–783) 960 (614–1262) <0.001
hO-1 preoperative (ng/ml) 7.34 (4.63–9.66) 6.98 (4.44–9.01) 6.29 (4.48–10.88) 0.83
hO-1 IcU (ng/ml) 12.81 (8.81–19.59) 12.91 (8.73–19.54) 11.65 (9.95–21.49) 0.88
hO-1 24 h (ng/ml) 9.71 (4.49–16.75) 8.30 (4.13–15.60) 12.75 (8.69–34.35) 0.031
Notes: Data is presented as median (IQR25, IQR75). The bold values are statistically significant.
Abbreviations: aKI, acute kidney injury; hO-1, heme oxygenase 1; IcU, intensive care unit; Ngal, neutrophil gelatinase-associated lipocalin.
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Figure 2  Plasma Ngal levels preoperatively and at arrival in IcU for patients with and without aKI occuring within 48 hours after cardiac surgery.
Notes: 0 refers to no aKI in 48 hours after surgery and 1 refers to aKI 48 hours after surgery. The circles and stars are markers in our statistics software sPss. The circles 
represent “out” values and stars represent “far out” values, based on interquartile range.
Abbreviations: aKI, acute kidney injury; aKI_48, acute kidney injury 48 hours after cardiac surgery; IcU, intensive care unit; Ngal, neutrophil gelatinase-associated 
lipocalin.
patients suffering from AKI demonstrated a higher rate in 
re-hospitalization, mortality and heart failure.6,8,9,23–25
HO-1 is upregulated in proximal tubular cells in response 
to oxidative stress and has protective anti-inflammatory and 
anti-oxidant effects.14 In rodent models, it has been associated 
with AKI.15 In cardiac surgery patients, it was associated with 
AKI after surgery in a very small sample of 74 patients,18 
which was a substudy of a clinical trial using ACE inhibitors 
to prevent inflammatory reactions after cardiac surgery. ACE 
inhibitors have been described to increase HO-1 expression 
and might be a bias in the prior study.26 Although in both stud-
ies the measurements were performed at the same time points, 
ICU arrival
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Figure 1 creatinine levels preoperatively, at arrival in IcU, and 24 and 48 hours postoperatively for patients with and without aKI occurring within 48 hours postoperatively.
Notes: 0 refers to no aKI in 48 hours after surgery and 1 refers to aKI 48 hours after surgery. The circles and stars are markers in our statistics software sPss. The circles 
represent “out” values and stars represent “far out” values, based on interquartile range.
Abbreviations: aKI, acute kidney injury; aKI_48, acute kidney injury 48 hours after cardiac surgery; hO-1, heme oxygenase 1; IcU, intensive care unit.
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the course of HO-1 levels differed. While we observed one 
burst of HO-1 post-CPB, the earlier cohort showed a decrease 
in HO-1. Furthermore, we showed a decrease of HO-1 in 
patients without AKI, which was not shown in the first study.
In our cohort, elevation of HO-1 serum concentrations 
after CPB was positively associated with the CPB time. 
The ischemia–reperfusion stress of the cross-clamping and 
diastolic arrest represent an intensive oxidative stress trig-
gering HO-1 production in different tissues.21,27,28 CPB time 
is a strong surrogate marker for the surgical complexity of 
the procedure itself and a complicated course during the 
operation.22 The longer a patient remains on CPB, the more 
oxidative stress is generated – not only in the myocardium 
but also in other sensitive tissues of the organism.21,22,28,29 Still 
the HO-1 elevation 24 hours after the surgery is a specific 
signal of renal stress. The first HO-1 induction does not 
differ between patients with or without AKI within the next 
48 hours. Thus, we assume that the renal stress caused by 
the CPB might not be the only cause for AKI in our cohort. 
Patients with prolonged CPB times tend to have higher inci-
dences of cardiogenic shock, anemia, bleeding, arrhythmia 
and pulmonary complications – all possible triggers of AKI 
for themselves.22,29–32 Our results might suggest that not 
the direct oxidative stress on the kidneys due to CPB is the 
causative for AKI, but the secondary upcoming complica-
tions and consequences of a long CPB duration.30,32 HO-1 
levels 24 hours after surgery are not any longer associated 
with the CPB time but with the incidence of AKI. This sec-
ond burst of HO-1 suggests that renal stress leading to AKI 
might be caused by, eg, inappropriate fluid management, 
diuretic treatment, appearance of cardiac shock or cardiac 
arrhythmias. Our results suggest that the time after surgery 
might be crucial for the development of AKI. Therefore, 
attention and targeted interventions to prevent AKI should be 
favorable during the postoperative phase, as already shown 
in literature.36
HO-1 measurements 24 hours after surgery were associ-
ated with the EuroScore II. EuroScore II is a risk score for 
cardiovascular surgery taking comorbidities, demography and 
other factors into consideration and providing a good sum 
up of all relevant operative risk factors.20 Thus, our results 
suggest that the renal oxidative stress might be caused or 
Table 3 aKI stages within 48 hours and 7 days after surgery
Variables All patients
aKI within 48 hours, n (%) (primary end point) 35 (23.5)
stage I 27 (18.0)
stage II 6 (4.0)
stage III 2 (1.3)
aKI within 7 days, n (%) 45 (30.2)
stage I 32 (21.3)
stage II 9 (6.0)
stage III 4 (2.7)
RRT, n (%) 3 (2.0)
Abbreviations: aKI, acute kidney injury; RRT, renal replacement therapy.
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Figure 3 Plasma hO-1 levels preoperatively, at arrival in IcU, and 24 hours postoperatively for patients with and without aKI occurring within 48 hours postoperatively.
Notes: 0 refers to no aKI in 48 hours after surgery and 1 refers to aKI 48 hours after surgery. The circles and stars are markers in our statistics software sPss. The circles 
represent “out” values and stars represent “far out” values, based on interquartile range.
Abbreviations: aKI, acute kidney injury; aKI_48, acute kidney injury 48 hours after cardiac surgery; hO-1, heme oxygenase 1; IcU, intensive care unit; Ngal, neutrophil 
gelatinase-associated lipocalin.
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influenced by the comorbidities of the patient, as described 
previously in recent literature34,35,37,38
Being a rather late marker after cardiac surgery, HO-1 
seems to be not helpful in clinical routine for early diagnostic 
issues after cardiac surgery compared to other biomarkers. 
Concurring with the literature we observed a statistically 
significant difference in HO-1 between AKI and no-AKI 
patients 24 hours after surgery.18  However, NGAL serum 
concentrations differed between the groups already after the 
CPB in our cohort, also according with the literature.39,41 But 
even NGAL does not provide an advantage over SCr to be of 
predictive value.  Biomarkers for detection of acute kidney 
1 – specificity
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Figure 4 ROc curves showing the interaction between creatinine levels at 6, 24, and 48 hours postop, Ngal  immediately postop, and serum hO-1 levels 24 hours postop, 
for the prediction of any stages of aKI occurring within 48 hours postoperatively.
Note: Diagonal segments are produced by ties.
Abbreviations: aKI, acute kidney injury; crea, creatinine; crea, creatinine; hO-1, heme oxygenase 1; Ngal, neutrophil gelatinase-associated lipocalin; postop, postoperative; 
ROc, receiver operating characteristic.
Table 4 Determinants of aKI development within 48 hours after cardiac surgery (unadjusted and adjusted logistic regression)
Variables Unadjusted (univariate 
analysis) P-value
Odds ratio (95% CI) Adjusted (multivariate 
analysis) P-value
Odds ratio 
(95% CI)
age 0.013 1.054 (1.011–1.099) 0.033 1.058 (1.005–1.114)
euroscore II 0.140 1.080 (0.975–1.196)
hypertension 0.404 1.440 (0.611–3.392)
Diabetes 0.217 2.044 (0.657–6.354)
cOPD 0.738 1.333 (0.247–7.192)
Peripheral artery disease 0.680 0.841 (0.370–1.914)
stroke 0.011 0.220 (0.069–0.707)
cPB time 0.013 1.010 (1.002–1.019) 0.031 1.012 (1.001–1.023)
Dhca 0.749 0.798 (0.200–3.184)
Mechanical ventilation time 0.006 1.071 (1.020–1.124)
Noradrenalin dose 0.001 1.090 (1.038–1.144 0.004 1.110 (1.034–1.192)
hO-1 24 h ng/ml <0.001 1.075 (1.035–1.117) 0.043 1.053 (1.002–1.107)
Resuscitation 0.382 0.442 (0.071–2.757)
hemodynamic instability 0.004 0.216 (0.076–0.614)
Rethoracotomy 0.339 0.485 (0.110–2.140)
Transfusions 0.001 0.269 (0.122–0.594)
Note: The bold values are statistically significant.
Abbreviations: aKI, acute kidney injury; cOPD, chronic obstructive pulmonary disease; cPB, cardiopulmonary bypass; Dhca, deep hypothermic circulatory arrest; hO-1, 
heme oxygenase 1.
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injury induced after the tubular damage has occurred are 
unsuitable for early diagnostics because the treatment options 
after the renal damage are limited.41 Some biomarkers, such 
as tissue inhibitor of metalloproteinase two and insulin-like 
growth factor binding protein 7 ([TIMP-2]*[IGFBP7]), 
seem to provide some significant timing advantage.41–44 In 
our cohort, HO-1 carried some benefits over other markers. 
In contrast to NGAL, HO-1 was very specific for AKI.40,45 
The HO-1 serum concentrations 24 hours after surgery had 
a specificity of over 91% for AKI. By contrast, NGAL con-
centrations in serum increase due to oxidative stress in other 
organs as well and are less specific for AKI.41 On the other 
hand, this association might be caused by the high cutoff 
level, and HO-1 elevation could be caused by general oxida-
tive stress. ([TIMP-2]*[IGFBP7] has a very high sensitivity 
of up to 90% in literature but has a rather low specificity 
(about 60%).44,46 With its high specificity, HO-1 might gather 
additional information about AKI especially in combination 
with other markers.
After cardiac surgery, serum NGAL levels have been 
shown to increase early within 2 hours and have already been 
proven to be predictive of the duration and severity of AKI 
after cardiac surgery.39 Recently, NGAL has been investigated 
extensively and appeared to be one of the most promising 
early biomarkers after renal injury.40  A meta-analysis includ-
ing 19 studies with 2,500 patients was performed to estimate 
the diagnostic and therapeutic accuracy of NGAL in AKI.33 In 
conclusion, NGAL was found to be a useful early predictor 
of AKI with prognostic value for clinical end points. Unfor-
tunately, substantial extrarenal NGAL generation in response 
to systemic stress can increase NGAL level in the absence of 
AKI,39 which partly limits its value in diagnostic accuracy.
Although the treating physicians were kept blinded 
regarding HO-1 and NGAL measurements, we address 
Table 5 ROc dates summarized for creatinine, Ngal postoperatively and serum hO-1 levels after 24 hours postoperatively for the 
prediction of aKI any stages in 48 hours
Variables AUC P-value SE 95% CI Cutoff Sensitivity (%) Specificity (%) PPV (%) NPV (%)
creatinine 6 h mg/dl 0.824 <0.001 0.054 0.719–0.929 1.00 94.4 63.3 40.3 94.4
creatinine 24 h mg/dl 0.857 <0.001 0.050 0.759–0.955 1.13 88.9 83.5 53.8 92.8
creatinine 48 mg/dl 0.893 <0.001 0.048 0.798–0.987 1.22 88.9 87.3 68.2 95.3
Ngal postop pg/ml 0.762 0.001 0.070 0.626–0.899 810 66.7 81 44.8 92
hO-1 24 h ng/ml 0.665 0.030 0.080 0.508–0.821 23.66 38.9 93.7 63.2 82.6
Note: The bold values are statistically significant.
Abbreviations: aUc, area under the curve; aKI, acute kidney injury; hO-1, heme oxygenase 1; Ngal, neutrophil gelatinase-associated lipocalin; NPV, negative predictive 
value; postop, postoperative; PPV, positive predictive value; ROc, receiver operating characteristic.
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Figure 5 ROc curves for serum hO-1 levels 24 hours postoperatively for the prediction of any stage of aKI (A) and stage 2 or 3 aKI (B) occurring within 48 hours 
postoperatively.
Abbreviations: aKI, acute kidney injury; hO-1, heme oxygenase 1; ROc, receiver operating characteristic.
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other limitations of the present study. A limited sample size 
prevents extensive multivariate adjustments, but this study 
still investigated the largest prospective cohort on HO-1 in 
cardiac surgery. Additionally, with the predefined exclusion 
criteria in our cohort, we could not study patients with pre-
existing advanced CKD and cannot comment or extrapolate 
on patients with CKD grade G4 or higher according to the 
KDIGO classification. Further information could be gath-
ered by measuring HO-1 in urine as well, but this was not 
depicted in the study protocol. Finally, there is a potential 
treatment bias, because our protocol did not involve pre-
defined approaches of treatment in case of postoperative AKI.
Conclusion
HO-1 measurements 24 hours after cardiac surgery are 
associated with AKI within 48 hours after surgery. Early 
measurements at ICU admission do not show any association 
with AKI. Further research on this marker in larger cohorts is 
important to characterize the entire value and determinants 
of the HO-1 kinetics. Clinical usefulness of this marker has 
yet to be investigated.
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